“Pharmacoepidemiology, Impacts of Anxiety Disorders and Anxiolytic Abuse before and During the COVID-19 Pandemic”. Research, Society and Development 11, no. 5 (April 9, 2022): e36111528340. Accessed April 1, 2026. https://www.rsdjournal.org/rsd/article/view/28340.